| Literature DB >> 36112591 |
Chance M Carbaugh1,2, William H van der Schalie1,3, Mark W Widder1.
Abstract
Engineered nanomaterials pose occupational health and environmental concerns as they possess unique physical and chemical properties that can contribute to toxicity. High throughput toxicity screening methods are needed to address the increasing number of nanomaterials in production. Here we used a zebrafish photomotor response (PMR) test to evaluate a set of fifteen nanomaterials with military relevance. Automated dechorionation of zebrafish embryos was used to enhance nanomaterials bioavailability. Optimal PMR activity in zebrafish embryos was found at 30-31 hours post-fertilization (hpf). Behavioral and toxicological responses were measured at 30 and 120 hpf; behavioral responses were found for thirteen of the fifteen nanomaterials and acute toxicity (LC50) levels for nine of the fifteen nanomaterials below the maximum test concentration of 500 μg/ml. Physico-chemical characterization of the nanomaterials detected endotoxin and bacterial contamination in two of the tested samples, which may have contributed to observed toxicity and reinforces the need for physical and chemical characterization of nanomaterials use in toxicity testing. The zebrafish PMR test, together with automated dechorionation, provides an initial rapid assessment of the behavioral effects and toxicity of engineered nanomaterials that can be followed up by physico-chemical characterization if toxicity is detected, reducing the amount of time and monetary constraints of physico-chemical testing.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36112591 PMCID: PMC9481008 DOI: 10.1371/journal.pone.0274011
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Fig 1Time series test for the photomotor response of zebrafish embryos.
Zebrafish photomotor response by phase. The graph depicts the control response of zebrafish embryos (n = 603) with increasing developmental age. Data generated from the PMR assay was further condensed using the area under the curve calculation by phase with standard deviation bars. Embryos that were found to be non-responders were excluded from the dataset. * = statistically significant increase in movement during the excitatory phase over the background phase.
| Testing Material | PMR (by phase) | Highest Concentration Tested (μg/mL) | 30 hpf LC50 (μg/mL) | 30 hpf EC50 (μg/mL) | 120 hpf LC50 (μg/mL) | 120 hpf EC50 (μg/mL) | ||
|---|---|---|---|---|---|---|---|---|
| Background (μg/mL) | Excitatory (μg/mL) | Refractory (μg/mL) | ||||||
| 30 nm Aluminum Oxide (alpha) | 50 | NA | None | 500 | 66.3 | ND | 67.4 | ND |
| 10 nm Aluminum Oxide (gamma) | >50 | >50 | None | 500 | >500 | ND | >500 | ND |
| 25 nm Cerium Oxide | >50 | 23.2 | None | 500 | 250 | 232 | 242 | 163 |
| 15–20 nm Iron Oxide | >50 | 23.2 | None | 500 | >500 | ND | >500 | ND |
| 20 nm Iron Oxide (gamma) | 23.2 | 50 | None | 500 | 142 | ND | 155 | ND |
| 20 nm Silica | 2.32 | None | None | 500 | >500 | ND | >500 | ND |
| 50 nm Silica | 2.32 | None | 10.7 | 500 | >500 | ND | >500 | ND |
| Silver Nitrate | 0.00232 | 0.0108 | None | 50 | 1.01 | 0.15 | 0.08 | 0.37 |
| 5 nm Silver | 0.5 | 0.5 | 0.108 | 50 | 3.81 | 2.37 | 0.71 | 2.34 |
| 25 nm Silver | 0.05 | 0.108 | None | 50 | 6.8 | 20 | 3.68 | 14.6 |
| 75 nm Silver | 0.108 | 1.08 | None | 500 | 154.26 | 189 | 33.1 | 74.9 |
| 75 nm Silver (NIST) | 0.232 | 0.5 | None | 50 | ND | ND | 43.3 | ND |
| 25 nm Titanium Oxide Nanopowder | None | 5 | None | 500 | 378 | ND | 325 | ND |
| 5–15 nm Titanium Oxide (rutile) | 50 | >50 | None | 500 | 302 | 411 | 284 | 434 |
| 30–50 nm Titanium Oxide (anatase) | 10.7 | >50 | None | 500 | >500 | ND | >500 | ND |
| 30–50 nm Titanium Oxide (rutile) | >50 | >50 | None | 500 | >500 | ND | >500 | ND |
Nanomaterial Effects on Zebrafish Embryos: PMR performed at 30 hpf, 30 hpf and 120 hpf mortality and morphological endpoints (LC50 and EC50). Lowest effect concentration shown for PMR tests with calculated p-value of less than 0.05. Nanomaterials that had a reported PMR of >50 μg/mL had observable behavioral effects but do to the turbidity of the wells at higher concentrations accurate detection with the tracking software could not be verified. Malformations were observed in only 0.007% of all the dechorionated control embryos.
Notes:
* = These PMR responses were hyperactive; all other PMR responses were hypoactive.
ND = These values could not be determined.
Fig 2Mortality curves of zebrafish embryos exposed to different nanomaterials.
120 hpf mortality curves of zebrafish embryos exposed to different nanomaterials. Mortality curves consist of multiple tests. If the concentrations between tests of the same nanomaterial overlapped, the average mortality at the concentration was reported in the mortality curve. This figure shows the mortality curve of silver nanomaterials based on size without the concentrations being adjusted for the ionic concentration of silver in solution. (120 hpf (LC50) for the silver nanomaterials are as followed: silver nitrate (0.08 μg/mL), 5 nm nano silver (0.71 μg/mL), 25 nm nano silver (3.68 μg/mL), 75 nm nano silver (33.1 μg/mL), and 75 nm nano silver (NIST) (43.3 μg/mL)).
|
|
|
|
| |||||||
|
|
|
|
|
|
|
|
|
|
| |
| Aluminum Oxide (alpha) | US Nano US7010 | 30 | 20% wt. | 30 ± 17 | 194 ± 2 | 0.07 ± 0.01 | Unsuccessful | 79 ± 20 | 15% wt. | 19% wt |
| Aluminum Oxide (gamma) | US Nano US7020 | 10 | 20% wt. | 24 ± 7 | 122 ± 2 | 0.14 ± 0.01 | Unsuccessful | 53 ± 28 | 10% wt. | 16% wt |
| Cerium Oxide | Sigma Aldrich 643009 (MKBW6379V) | <25 | 10% wt. | Aggregates/ Agglomerates | 257 ± 11 | 0.15 ± 0.02 | Not Tested | 141 ± 42 | 17% wt. | 20% wt. |
| Iron Oxide | US Nano US7568 | 15–20 | 20% wt. | 12 ± 4 | 238 ± 15 | 0.25 ± 0.01 | Major: 34–100 Minor: 100–260 | 68 ± 12 | 9% wt. | 11% wt. |
| Iron Oxide (gamma) | US Nano US7558 | 20 | 10% wt. | Aggregation/ Agglomeration | 242 ± 26 | 0.34 ± 0.02 | Not Tested | 107 ± 38 | 15% wt. | 26% wt. |
| Silica Nanospheres | nanoComposix JEA0156 (MEL0010) | 20 ± 4 | 10 mg/mL | 23 ± 4 | 29 ± 0 | 0.11 ± 0.01 | Major: 25–37 Minor: 174–184 | - | - | 4.0 mg/mL |
| Silica Nanospheres | nanoComposix JEA0088 (MEL0053) | 50 ± 4 | 10 mg/mL | 48 ± 5 | 58 ± 0 | 0.02 ± 0.01 | Not Tested | - | - | 9.1 mg/mL |
| Silver | nanoComposix KJW1980A (ECP1598) | 5 ± 2 | 5 mg/mL | 5 ± 1 | 14 ± 3 | 0.45 ± 0.02 | Major: 14–23 Minor: 46–160 | - | 4.62 ± 0.05 mg/mL | 7.8 mg/mL |
| Silver | nanoComposix CLF0494A (DAC1541) | 25 ± 5 | 5 mg/mL | 7 ± 2 24 ± 5 | 5 ± 0 | 0.56 ± 0.01 | Major: 25–26 Minor: 12–15 | - | 4.51 ± 0.05 mg/mL | 3.5 mg/mL |
| Silver | nanoComposix DMW0382 (ALJ0044) | 75 ± 5 | 5 mg/mL | 83 ± 9 | 121 ± 2 | 0.08 ± 0.02 | 103–139 | - | 4.49 ± 0.04 mg/mL | 2.2 mg/mL |
| Silver | National Institute of Standards and Technology (NIST) | 75 | 1 mg/mL | - | - | - | - | - | - | - |
| Titanium Oxide Nanopowder | ECONIK 614031098 | 25 | - | - | - | - | - | - | - | - |
| Titanium Oxide (rutile) | US Nano US7050 | 5–15 | 15% wt. | 63 ± 19 | 683 ± 209 | 0.29 ± 0.06 | Major: 43–200 Minor: 285–320 | 72 ± 20 | 12% wt. | 15% wt. |
| Titanium Oxide (anatase) | US Nano US7071 | 30–50 | 40% wt. | 41 ± 14 | 219 ± 36 | 0.28 ± 0.03 | Not Tested | 231 ± 66 | 39% wt. | 36% wt. |
| Titanium Oxide (rutile) | US Nano US7070 | 30–50 | 20% wt. | 55 ± 15 | 780 ± 68 | 0.22 ± 0.03 | Unsuccessful | 42 ± 22 | 7% wt. | 9% wt. |
|
|
|
|
|
| ||||||
|
|
|
|
|
|
|
|
|
|
| |
| Aluminum Oxide (alpha) | Negative | <0.5 | Possible | Unknown | 5% | 25 ± 2 | Y, Zr, Hf | <0.1% (15 June 2016) | <0.1% (30 August 2016) | <0.3% (30 November 2016) |
| Aluminum Oxide (gamma) | Negative | <0.5 | Possible | Unknown but different than US7010 | 23% | 45 ± 1 | Zn | 0.1% (15 June 2016) | <0.1% (30 August 2016) | <0.1% (30 November 2016) |
| Cerium Oxide | Not Tested | Not Tested | - | - | - | 18 ± 2 | None | - | - | - |
| Iron Oxide | Negative | <0.05 | Possible | Unknown | 15% | -36 ± 0 | Mn, Zn | 0.8% (09 June 2016) | 1.2% (26 August 2016) | 0.3% (21 November 2016) |
| Iron Oxide (gamma) | Bacteria 72,000 | 6170 | Possible | Unknown | 17% | -36 ± 1 | Mn, Zn | 2.5% (09 June 2016) | 1.8% (26 August 2016) | 1.8% (21 November 2016) |
| Silica Nanospheres | Negative | 3.1 | Possible | Unknown | 13% | -27 ± 1 | - | - | - | - |
| Silica Nanospheres | Mold | <0.005 | Possible | Unknown | 19% | -53 ± 4 | - | - | - | - |
| Silver | Negative | 1.9 | Yes | Polyvinylpyrrolidone (per manufacturer; size unknown) | 29% | -33 ± 0 | Zn | 5.1% (01 June 2016) | 18% (31 August 2016) | - |
| Silver | Negative | <5 | Yes | Polyvinylpyrrolidone (per manufacturer; size unknown) | 5% | -20 ± 1 | Zn, Cu | 1.2% (01 June 2016) | 13% (31 August 2016) | - |
| Silver | Negative | 2.5 | Yes | Polyvinylpyrrolidone (per manufacturer; size unknown) | 15% | -24 ± 1 | Zn | 0.4% (01 June 2016) | 2.5% (31 August 2016) | - |
| Silver | - | - | - | - | - | - | - | - | - | - |
| Titanium Oxide Nanopowder | - | - | - | - | - | - | - | - | - | - |
| Titanium Oxide (rutile) | 310 | 28 | Possible | Unknown | 10% | -20 ± 1 | Zn, Hf | 0% (28 September 2016) | <0.1% (29 November 2016) | - |
| Titanium Oxide (anatase) | Negative | <0.5 | Possible | Unknown | 10% | -12 ± 0 | V, Mn, Fe, Zn, Sr, Ce, Pb, U | 0% (28 September 2016) | <0.1% (29 November 2016) | - |
| Titanium Oxide (rutile) | Negative | <0.05 | Possible | Unknown | 1% | 7 ± 1 | Zn,Zr,Sn | 0% (28 September 2016) | 0.1% (29 November 2016) | - |
Nanomaterial physico-chemical data. Physical chemical data obtained from the NCL’s final report on the nanomaterials. For nanomaterials that have two lot numbers the lot number that is in parentheses and is in bold face was the lot that was tested for toxicity testing but was not tested by the NCL for its physical chemical properties. Nanomaterials that did not have a concentration listed for the section "manufacturer reported values" were in powder form and prepared following the manufacturer’s instructions.
Fig 3Mortality curves of zebrafish embryos exposed to different nanomaterials.
120 hpf mortality curves of zebrafish embryos exposed to different nanomaterials. Mortality curves consist of multiple tests. If the concentrations between tests of the same nanomaterial overlapped, the average mortality at the concentration was reported in the mortality curve. This figure shows the mortality curves of silver nanomaterials with the concentrations adjusted for the concentration of ionic silver in solution. (120 hpf (LC50) for the silver nanomaterials with adjusted concentrations are as followed: silver nitrate (0.08 μg/mL), 5 nm nano silver (0.03 μg/mL), 25 nm nano silver (0.04 μg/mL), and 75 nm nano silver (0.16 μg/mL)).